174 related articles for article (PubMed ID: 37815873)
21. The Epigenetic Modulation of Cancer and Immune Pathways in Hepatitis B Virus-Associated Hepatocellular Carcinoma: The Influence of HBx and miRNA Dysregulation.
Sartorius K; An P; Winkler C; Chuturgoon A; Li X; Makarova J; Kramvis A
Front Immunol; 2021; 12():661204. PubMed ID: 33995383
[TBL] [Abstract][Full Text] [Related]
22. Hepatitis B virus core promoter mutations contribute to hepatocarcinogenesis by deregulating SKP2 and its target, p21.
Huang Y; Tong S; Tai AW; Hussain M; Lok AS
Gastroenterology; 2011 Oct; 141(4):1412-21, 1421.e1-5. PubMed ID: 21704589
[TBL] [Abstract][Full Text] [Related]
23. A positive-feedback loop between HBx and ALKBH5 promotes hepatocellular carcinogenesis.
Qu S; Jin L; Huang H; Lin J; Gao W; Zeng Z
BMC Cancer; 2021 Jun; 21(1):686. PubMed ID: 34112124
[TBL] [Abstract][Full Text] [Related]
24. Hepatitis B virus x protein in the pathogenesis of hepatitis B virus-induced hepatocellular carcinoma.
Kew MC
J Gastroenterol Hepatol; 2011 Jan; 26 Suppl 1():144-52. PubMed ID: 21199526
[TBL] [Abstract][Full Text] [Related]
25. Promyelocytic leukaemia protein links DNA damage response and repair to hepatitis B virus-related hepatocarcinogenesis.
Chung YL; Wu ML
J Pathol; 2013 Aug; 230(4):377-87. PubMed ID: 23620081
[TBL] [Abstract][Full Text] [Related]
26. Expression of B7-H4 and hepatitis B virus X in hepatitis B virus-related hepatocellular carcinoma.
Hong B; Qian Y; Zhang H; Sang YW; Cheng LF; Wang Q; Gao S; Zheng M; Yao HP
World J Gastroenterol; 2016 May; 22(18):4538-46. PubMed ID: 27182163
[TBL] [Abstract][Full Text] [Related]
27. Hepatitis B virus X protein-elevated MSL2 modulates hepatitis B virus covalently closed circular DNA by inducing degradation of APOBEC3B to enhance hepatocarcinogenesis.
Gao Y; Feng J; Yang G; Zhang S; Liu Y; Bu Y; Sun M; Zhao M; Chen F; Zhang W; Ye L; Zhang X
Hepatology; 2017 Nov; 66(5):1413-1429. PubMed ID: 28608964
[TBL] [Abstract][Full Text] [Related]
28. Hepatitis B virus-induced hepatocellular carcinoma.
Xu C; Zhou W; Wang Y; Qiao L
Cancer Lett; 2014 Apr; 345(2):216-22. PubMed ID: 23981576
[TBL] [Abstract][Full Text] [Related]
29. Interplay between SIRT1 and hepatitis B virus X protein in the activation of viral transcription.
Deng JJ; Kong KE; Gao WW; Tang HV; Chaudhary V; Cheng Y; Zhou J; Chan CP; Wong DK; Yuen MF; Jin DY
Biochim Biophys Acta Gene Regul Mech; 2017 Apr; 1860(4):491-501. PubMed ID: 28242208
[TBL] [Abstract][Full Text] [Related]
30. Epigenetic silencing of SFRP1 and SFRP5 by hepatitis B virus X protein enhances hepatoma cell tumorigenicity through Wnt signaling pathway.
Xie Q; Chen L; Shan X; Shan X; Tang J; Zhou F; Chen Q; Quan H; Nie D; Zhang W; Huang AL; Tang N
Int J Cancer; 2014 Aug; 135(3):635-46. PubMed ID: 24374650
[TBL] [Abstract][Full Text] [Related]
31. All-
Han J; Jang KL
Viruses; 2023 Jun; 15(7):. PubMed ID: 37515144
[TBL] [Abstract][Full Text] [Related]
32. Altered proteolysis and global gene expression in hepatitis B virus X transgenic mouse liver.
Hu Z; Zhang Z; Kim JW; Huang Y; Liang TJ
J Virol; 2006 Feb; 80(3):1405-13. PubMed ID: 16415018
[TBL] [Abstract][Full Text] [Related]
33. Upregulated FoxM1 expression induced by hepatitis B virus X protein promotes tumor metastasis and indicates poor prognosis in hepatitis B virus-related hepatocellular carcinoma.
Xia L; Huang W; Tian D; Zhu H; Zhang Y; Hu H; Fan D; Nie Y; Wu K
J Hepatol; 2012 Sep; 57(3):600-12. PubMed ID: 22613004
[TBL] [Abstract][Full Text] [Related]
34. Tumor hepatitis B virus RNA identifies a clinically and molecularly distinct subset of hepatocellular carcinoma.
Lim HC; Gordan JD
PLoS Comput Biol; 2021 Feb; 17(2):e1008699. PubMed ID: 33561166
[TBL] [Abstract][Full Text] [Related]
35. Metformin inhibits tumorigenesis in HBV-induced hepatocellular carcinoma by suppressing HULC overexpression caused by HBX.
Jiang Z; Liu H
J Cell Biochem; 2018 Jun; 119(6):4482-4495. PubMed ID: 29231260
[TBL] [Abstract][Full Text] [Related]
36. Downregulation of microRNA-15b by hepatitis B virus X enhances hepatocellular carcinoma proliferation via fucosyltransferase 2-induced Globo H expression.
Wu CS; Yen CJ; Chou RH; Chen JN; Huang WC; Wu CY; Yu YL
Int J Cancer; 2014 Apr; 134(7):1638-47. PubMed ID: 24122375
[TBL] [Abstract][Full Text] [Related]
37. Upregulated in Hepatitis B virus-associated hepatocellular carcinoma cells, miR-331-3p promotes proliferation of hepatocellular carcinoma cells by targeting ING5.
Cao Y; Chen J; Wang D; Peng H; Tan X; Xiong D; Huang A; Tang H
Oncotarget; 2015 Nov; 6(35):38093-106. PubMed ID: 26497554
[TBL] [Abstract][Full Text] [Related]
38. No expression of HBV-human chimeric fusion transcript (HBx-LINE1) among Vietnamese patients with HBV-associated hepatocellular carcinoma.
Trung NT; Hai LT; Giang DP; Hoan PQ; Binh MT; Hoan NX; Toan NL; Meyer CG; Velavan TP; Bang MH; Song LH
Ann Hepatol; 2019; 18(2):404-405. PubMed ID: 31036498
[No Abstract] [Full Text] [Related]
39. Type-III interferon stimulated gene TRIM31 mutation in an HBV patient blocks its ability in promoting HBx degradation.
Xu F; Song H; Xiao Q; Wei Q; Pang X; Gao Y; Tan G
Virus Res; 2022 Jan; 308():198650. PubMed ID: 34863820
[TBL] [Abstract][Full Text] [Related]
40. Hepatitis B virus X protein promotes DNA damage propagation through disruption of liver polyploidization and enhances hepatocellular carcinoma initiation.
Ahodantin J; Bou-Nader M; Cordier C; Mégret J; Soussan P; Desdouets C; Kremsdorf D
Oncogene; 2019 Apr; 38(14):2645-2657. PubMed ID: 30538294
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
